Breaking News, Promotions & Moves

Nkarta Appoints SVP & CMO

Dr. Kanya Rajangam is an experienced biotechnology executive with a track record of successfully developing cancer therapies

Nkarta Therapeutics has named Kanya Rajangam, M.D., Ph.D., as senior vice president and chief medical officer.     Dr. Rajangam, who will be joining the company in December, is an experienced biotechnology executive with a track record of successfully developing cancer therapies.  She replaces interim chief medical officer, Angela Shen, M.D., M.B.A.  “We are thrilled to have Kanya join our team, and we look forward to her leadership in bringing our promising technology to patients...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters